Invasion of Tumorigenic HT1080 Cells Is Impeded by Blocking or Downregulating the 37-kDa/67-kDa Laminin Receptor

Journal of Molecular Biology

Volumn 378, Issue 3, 2008, Pages 530-539

  Zuber, Chantal ^a   Knackmuss, Stefan ^b   Zemora, Georgeta ^a   Reusch, Uwe ^b   Vlasova, Ekaterina ^a   Diehl, Daniela ^a   Mick, Vera ^b   Hoffmann, Karin ^b   Nikles, Daphne ^a   Fröhlich, Thomas ^a   Arnold, Georg J ^a   Brenig, Bertram ^c   Wolf, Eckhard ^a   Lahm, Harald ^a   Little, Melvyn ^b   Weiss, Stefan ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Affimed GmbH   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

cancer; laminin receptor; metastasis; prion; therapy

Indexed keywords

IMMUNOGLOBULIN G1; LAMININ 1; LAMININ RECEPTOR; PENTOSAN POLYSULFATE; PRION PROTEIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL ADHESION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; WESTERN BLOTTING;

EID: 42449160941     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.02.004     Document Type: Article

References (44)

1. Givant-Horwitz V., Davidson B., and Reich R. Laminin-induced signaling in tumor cells. Cancer Lett. 223 (2005) 1-10
2. Landowski T.H., Uthayakumar S., and Starkey J.R. Control pathways of the 67 kDa laminin binding protein: surface expression and activity of a new ligand binding domain. Clin. Exp. Metastasis 13 (1995) 357-372
3. Ardini E., Sporchia B., Pollegioni L., Modugno M., Ghirelli C., Castiglioni F., et al. Identification of a novel function for 67-kDa laminin receptor: increase in laminin degradation rate and release of motility fragments. Cancer Res. 62 (2002) 1321-1325
4. McKenna D.J., Simpson D.A., Feeney S., Gardiner T.A., Boyle C., Nelson J., and Stitt A.W. Expression of the 67 kDa laminin receptor (67LR) during retinal development: correlations with angiogenesis. Exp. Eye Res. 73 (2001) 81-92
5. Tanaka M., Narumi K., Isemura M., Abe M., Sato Y., Abe T., et al. Expression of the 37-kDa laminin binding protein in murine lung tumor cell correlates with tumor angiogenesis. Cancer Lett. 153 (2000) 161-168
6. Gauczynski S., Peyrin J.M., Haik S., Leucht C., Hundt C., Rieger R., et al. The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J. 20 (2001) 5863-5875
7. Gauczynski S., Nikles D., El-Gogo S., Papy-Garcia D., Rey C., Alban S., et al. The 37-kDa/67-kDa laminin receptor acts as a receptor for infectious prions and is inhibited by polysulfated glycanes. J. Infect. Dis. 194 (2006) 702-709
8. Thepparit C., and Smith D.R. Serotype-specific entry of dengue virus into liver cells: identification of the 37-kilodalton/67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptor. J. Virol. 78 (2004) 12647-12656
9. Ludwig G.V., Kondig J.P., and Smith J.F. A putative receptor for Venezuelan equine encephalitis virus from mosquito cells. J. Virol. 70 (1996) 5592-5599
10. Wang K.S., Kuhn R.J., Strauss E.G., Ou S., and Strauss J.H. High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells. J. Virol. 66 (1992) 4992-5001
11. Akache B., Grimm D., Pandey K., Yant S.R., Xu H., and Kay M.A. The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9. J. Virol. 80 (2006) 9831-9836
12. Ludewigs H., Zuber C., Vana K., Nikles D., Zerr I., and Weiss S. Therapeutic approaches for prion disorders. Expert Rev. Anti-Infect. Ther. 5 (2007) 613-630
13. Vana K., Zuber C., Nikles D., and Weiss S. Novel aspects of prions, their receptor molecules, and innovative approaches for TSE therapy. Cell. Mol. Neurobiol. 27 (2007) 107-128
14. Zuber C., Ludewigs H., and Weiss S. Therapeutic approaches targeting the prion receptor LRP/LR. Vet. Microbiol. 123 (2007) 387-393
15. Tseng J.C., Levin B., Hurtado A., Yee H., Perez de Castro I., Jimenez M., et al. Systemic tumor targeting and killing by Sindbis viral vectors. Nat. Biotechnol. 22 (2004) 70-77
16. Simoneau S., Haik S., Leucht C., Dormont D., Deslys J.P., Weiss S., and Lasmezas C. Different isoforms of the non-integrin laminin receptor are present in mouse brain and bind PrP. Biol. Chem. 384 (2003) 243-246
17. Menard S., Castronovo V., Tagliabue E., and Sobel M.E. New insights into the metastasis-associated 67 kD laminin receptor. J. Cell. Biochem. 67 (1997) 155-165
18. Ziober B.L., Lin C.S., and Kramer R.H. Laminin-binding integrins in tumor progression and metastasis. Semin. Cancer Biol. 7 (1996) 119-128
19. Castronovo V., Taraboletti G., and Sobel M.E. Functional domains of the 67-kDa laminin receptor precursor. J. Biol. Chem. 266 (1991) 20440-20446
20. Magnifico A., Tagliabue E., Buto S., Ardini E., Castronovo V., Colnaghi M.I., and Menard S. Peptide G, containing the binding site of the 67-kDa laminin receptor, increases and stabilizes laminin binding to cancer cells. J. Biol. Chem. 271 (1996) 31179-31184
21. Sobel M.E. Differential expression of the 67 kDa laminin receptor in cancer. Semin. Cancer Biol. 4 (1993) 311-317
22. Hunt G. The role of laminin in cancer invasion and metastasis. Exp. Cell Biol. 57 (1989) 165-176
23. Romanov V., Sobel M.E., pinto da Silva P., Menard S., and Castronovo V. Cell localization and redistribution of the 67 kD laminin receptor and alpha 6 beta 1 integrin subunits in response to laminin stimulation: an immunogold electron microscopy study. Cell Adhes. Commun. 2 (1994) 201-209
24. Berno V., Porrini D., Castiglioni F., Campiglio M., Casalini P., Pupa S.M., et al. The 67 kDa laminin receptor increases tumor aggressiveness by remodeling laminin-1. Endocr.-Relat. Cancer 12 (2005) 393-406
25. Zuber C., Knackmuss S., Rey C., Reusch U., Rottgen P., Frohlich T., et al. Single chain Fv antibodies directed against the 37 kDa/67 kDa laminin receptor as therapeutic tools in prion diseases. Mol. Immunol. 45 (2008) 144-151
26. Leucht C., Simoneau S., Rey C., Vana K., Rieger R., Lasmezas C.I., and Weiss S. The 37 kDa/67 kDa laminin receptor is required for PrP(Sc) propagation in scrapie-infected neuronal cells. EMBO Rep. 4 (2003) 290-295
27. Zuber C., Mitteregger G., Pace C., Kretzschmar H.A., Zerr I., and Weiss S. Anti-LRP/LR antibody W3 hampers peripheral PrPSc propagation in scrapie infected mice. Prion 1 (2007) 207-212
28. Liu D., Shriver Z., Qi Y., Venkataraman G., and Sasisekharan R. Dynamic regulation of tumor growth and metastasis by heparan sulfate glycosaminoglycans. Semin. Thromb. Hemostasis 28 (2002) 67-78
29. Montuori N., Selleri C., Risitano A.M., Raiola A.M., Ragno P., Del Vecchio L., et al. Expression of the 67-kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation. Clin. Cancer Res. 5 (1999) 1465-1472
30. Satoh K., Narumi K., Abe T., Sakai T., Kikuchi T., Tanaka M., et al. Diminution of 37-kDa laminin binding protein expression reduces tumour formation of murine lung cancer cells. Br. J. Cancer 80 (1999) 1115-1122
31. Shen X., and Falzon M. PTH-related protein upregulates integrin alpha6beta4 expression and activates Akt in breast cancer cells. Exp. Cell Res. 312 (2006) 3822-3834
32. Chakrabarti J., Mitra A., Banerji A., and Chatterjee A. Culture of human fibrosarcoma HT-1080 cells in presence of fibronectin activates MMP-2. J. Environ. Pathol., Toxicol. Oncol. 25 (2006) 667-677
33. Rubin H., and Xu K. Evidence for the progressive and adaptive nature of spontaneous transformation in the NIH 3T3 cell line. Proc. Natl Acad. Sci. USA 86 (1989) 1860-1864
34. Ellison B.J., and Rubin H. Individual transforming events in long-term cell culture of NIH 3T3 cells as products of epigenetic induction. Cancer Res. 52 (1992) 667-673
35. Auth D., and Brawerman G. A 33-kDa polypeptide with homology to the laminin receptor: component of translation machinery. Proc. Natl Acad. Sci. USA 89 (1992) 4368-4372
36. Sato M., Kinoshita K., Kaneda Y., Saeki Y., Iwamatsu A., and Tanaka K. Analysis of nuclear localization of laminin binding protein precursor p40 (LBP/p40). Biochem. Biophys. Res. Commun. 229 (1996) 896-901
37. Sanderson R.D. Heparan sulfate proteoglycans in invasion and metastasis. Semin. Cell Dev. Biol. 12 (2001) 89-98
38. Fjeldstad K., and Kolset S.O. Decreasing the metastatic potential in cancers-targeting the heparan sulfate proteoglycans. Curr. Drug Targets 6 (2005) 665-682
39. Parish C.R., Freeman C., Brown K.J., Francis D.J., and Cowden W.B. Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity. Cancer Res. 59 (1999) 3433-3441
40. Hundt C., Peyrin J.-M., Haik S., Gauczynski S., Leucht C., Rieger R., et al. Identification of interaction domains of the prion protein with its 37kDa/67kDa laminin receptor. EMBO J. 20 (2001) 5876-5886
41. Ferro V., Dredge K., Liu L., Hammond E., Bytheway I., Li C., et al. PI-88 and novel heparan sulfate mimetics inhibit angiogenesis. Semin. Thromb. Hemostasis 33 (2007) 557-568
42. Rieger R., Edenhofer F., Lasmezas C.I., and Weiss S. The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells. Nat. Med. 3 (1997) 1383-1388
43. Persic L., Roberts A., Wilton J., Cattaneo A., Bradbury A., and Hoogenboom H.R. An integrated vector system for the eukaryotic expression of antibodies or their fragments after selection from phage display libraries. Gene 187 (1997) 9-18
44. Frank R. SPOT-synthesis: an easy technique for the positionally addressable parallel chemical synthesis on a membrane support. Tetrahedron 48 (1992) 9217